This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aoyagi, M. Articles by Yamamoto, K. Search for Related Content PubMed PubMed Citation Articles by Aoyagi, M. Articles by Yamamoto, K. Pubmed/NCBI databases OMIM

(Stroke. 1995;26:415-417.)
© 1995 American Heart Association, Inc.

Articles

Human Leukocyte Antigen in Patients With Moyamoya Disease

Masaru Aoyagi, MD; Kazuo Ogami, BS; Yoshiharu Matsushima, MD; Manabu Shikata, BS; Mari Yamamoto, PhD Kiyotaka Yamamoto, PhD

From the Department of Neurosurgery, Tokyo Medical and Dental University, Bunkyo-ku (M.A., Y.M.), and the Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku (M.A., K.O., M.S., M.Y., K.Y.), Tokyo, Japan.

Correspondence to Masaru Aoyagi, MD, Department of Neurosurgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113, Japan.

Background and Purpose Progressive stenosis or occlusion of bilateral internal carotid arteries by fibrocellular intimal thickening results in cerebral ischemia in moyamoya disease. In an attempt to elucidate the still-unknown etiologic factors in moyamoya disease, we assessed human leukocyte antigens in patients with this disease.

Methods We investigated 32 unrelated Japanese patients with moyamoya disease for typing of human leukocyte antigen A, B, C, and DR/DQ and compared the results with those from 178 unrelated control subjects.

Results We found a significant association of human leukocyte antigen B51 with moyamoya disease (corrected P<.05, ² test). Although no significant associations were observed in DR/DQ typing, the frequency of the B51-DR4 combination was significantly higher in moyamoya patients than in control subjects (P<.002, Fisher's exact test).

Conclusions These findings suggest that there may be a genetic predisposition for moyamoya disease and that host factors may play a role in the development of intimal thickening in early childhood.

Key Words: cerebrovascular disease • leukocytes • moyamoya disease

This article has been cited by other articles:

				F. J. Kirkham, M. Prengler, D. K.M. Hewes, and V. Ganesan Risk Factors for Arterial Ischemic Stroke in Children J Child Neurol, May 1, 2000; 15(5): 299 - 307. [Abstract] [PDF]

				A. J. Grau, T. Brandt, F. Buggle, E. Orberk, J. Mytilineos, E. Werle, C. Conradt, M. Krause, R. Winter, and W. Hacke Association of Cervical Artery Dissection With Recent Infection Arch Neurol, July 1, 1999; 56(7): 851 - 856. [Abstract] [Full Text] [PDF]

				M. Yamamoto, M. Aoyagi, N. Fukai, Y. Matsushima, and K. Yamamoto Differences in Cellular Responses to Mitogens in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease Stroke, June 1, 1998; 29(6): 1188 - 1193. [Abstract] [Full Text] [PDF]

				J. Lutterman, M. Scott, R. Nass, and T. Geva Moyamoya Syndrome Associated With Congenital Heart Disease Pediatrics, January 1, 1998; 101(1): 57 - 60. [Abstract] [Full Text] [PDF]

				M. Aoyagi, N. Fukai, M. Yamamoto, K. Nakagawa, Y. Matsushima, and K. Yamamoto Early Development of Intimal Thickening in Superficial Temporal Arteries in Patients With Moyamoya Disease Stroke, October 1, 1996; 27(10): 1750 - 1754. [Abstract] [Full Text]